Literature DB >> 11720866

1-Alkyl-3-amino-5-aryl-1H-[1,2,4]triazoles: novel synthesis via cyclization of N-acyl-S-methylisothioureas with alkylhydrazines and their potent corticotropin-releasing factor-1 (CRF(1)) receptor antagonist activities.

C Chen1, R Dagnino, C Q Huang, J R McCarthy, D E Grigoriadis.   

Abstract

Cyclizations of alkylhydrazines with N-acyl-S-methylisothioureas, readily synthesized from acyl chlorides, sodium thioisocyanate, dialkylamines then methyl iodide in a one-pot reaction, gave 1-alkyl-3-dialkylamino-5-phenyltriazoles 7 as major products. The regioisomers were assigned through the use of NOE NMR experiments. While bearing a N-bis(cyclopropyl)methyl-N-propylamino group, this series of compounds shows very good binding affinity on the human CRF(1) receptor. Among them, 1-methyl-3-[N-bis(cyclopropyl)methyl-N-propylamino]-5-(2,4-dichlorophenyl)-1H-[1,2,4]triazole 7a had the best binding affinity for the CRF(1) receptor (K(i)=9 nM).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720866     DOI: 10.1016/s0960-894x(01)00657-6

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Small molecule antagonists of the TGF-beta1/TGF-beta receptor binding interaction.

Authors:  James K Burmester; Sherry A Salzman; Kai Qi Zhang; Richard A Dart
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  3-Dialkylamino-1,2,4-triazoles via ZnII-Catalyzed Acyl Hydrazide-Dialkylcyanamide Coupling.

Authors:  Sevilya N Yunusova; Dmitrii S Bolotin; Vitalii V Suslonov; Mikhail A Vovk; Peter M Tolstoy; Vadim Yu Kukushkin
Journal:  ACS Omega       Date:  2018-07-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.